Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 26254053.
- Also identified by DOI 10.1016/j.jaci.2015.05.027 and PMC identifier 4529958.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Allergic reactions to drugs are a serious public health concern. In 2013, the Division of Allergy, Immunology, and Transplantation of the National Institute of Allergy and Infectious Diseases sponsored a workshop on drug allergy. International experts in the field of drug allergy with backgrounds in allergy, immunology, infectious diseases, dermatology, clinical pharmacology, and pharmacogenomics discussed the current state of drug allergy research. These experts were joined by representatives from several National Institutes of Health institutes and the US Food and Drug Administration. The participants identified important advances that make new research directions feasible and made suggestions for research priorities and for development of infrastructure to advance our knowledge of the mechanisms, diagnosis, management, and prevention of drug allergy. The workshop summary and recommendations are presented herein.
Medical subject headings
- Drug Hypersensitivity
- Stevens-Johnson Syndrome
- Translational Research, Biomedical
- Virus Diseases